IR Resources

Investor Contact

Julissa Viana

Investor Relations

Ryan Porter

Argot Partners
+1 212-600-1902

Email Alerts

You may automatically receive Verastem Oncology financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit.

Investor FAQ

On which exchange is Verastem Oncology™ listed and what is the ticker symbol and when did it go public?

Verastem Oncology is traded on the NASDAQ Capital Market under the symbol VSTM, and its CUSIP number is 92337C203. Verastem’s initial public offering (IPO) occurred on January 27, 2012.

Where is Verastem Oncology incorporated?

Verastem Oncology is incorporated in the state of Delaware.

Where is Verastem Oncology headquartered?

Verastem Oncology is headquartered at 117 Kendrick Street, Suite 500, Needham, MA 02494, U.S. The main phone number is 781-292-4200.

Do you pay dividends or is there a reimbursement plan?

Verastem Oncology does not currently offer a dividend or stock reimbursement plan.

Who is Verastem Oncology’s transfer agent?

Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940
1-800-962-4284 (from the US, Canada, Puerto Rico)
1-781-575-3120 (non-US)

If my address changes, whom should I notify?

You must send both your old and new address to our transfer agent, Computershare Trust Company, N.A., by U.S. mail. Each stockholder in question must sign the request for an address change.

What is Verastem Oncology’s fiscal year-end?

December 31.

Who are Verastem Oncology’s independent auditors?

Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116

Who is Verastem Oncology’s legal counsel?

Ropes & Gray
Prudential Tower
800 Boylston Street
Boston, MA 02199-3600
T +1 617 951 7000

Who should I contact if I have further questions?

Verastem Oncology's investor relations department is happy to answer any shareholder questions. You may contact Verastem Oncology's investor relations by phone at 781-292-4200, or by email at